Royal Bank of Canada’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88K | Buy |
7,972
+6,228
| +357% | +$68.7K | ﹤0.01% | 5332 |
|
|
2025
Q1 | $22K | Buy |
1,744
+998
| +134% | +$12.6K | ﹤0.01% | 5499 |
|
|
2024
Q4 | $8K | Sell |
746
-1,074
| -59% | -$11.5K | ﹤0.01% | 5914 |
|
|
2024
Q3 | $13K | Buy |
1,820
+537
| +42% | +$3.84K | ﹤0.01% | 5796 |
|
|
2024
Q2 | $10K | Buy |
+1,283
| New | +$10K | ﹤0.01% | 5950 |
|
|
2024
Q1 | – | Sell |
-118
| Closed | -$1K | – | 6823 |
|
|
2023
Q4 | $1K | Buy |
118
+114
| +2,850% | +$966 | ﹤0.01% | 6411 |
|
|
2023
Q3 | $0 | Sell |
4
-337
| -99% | – | ﹤0.01% | 6837 |
|
|
2023
Q2 | $2K | Buy |
+341
| New | +$2K | ﹤0.01% | 6431 |
|
|
2023
Q1 | – | Sell |
-58
| Closed | – | – | 6838 |
|
|
2022
Q4 | $0 | Sell |
58
-171
| -75% | – | ﹤0.01% | 7008 |
|
|
2022
Q3 | $1K | Buy |
229
+81
| +55% | +$354 | ﹤0.01% | 6734 |
|
|
2022
Q2 | $1K | Sell |
148
-288
| -66% | -$1.95K | ﹤0.01% | 6694 |
|
|
2022
Q1 | $4K | Sell |
436
-1,292
| -75% | -$11.9K | ﹤0.01% | 6839 |
|
|
2021
Q4 | $17K | Buy |
1,728
+894
| +107% | +$8.8K | ﹤0.01% | 6331 |
|
|
2021
Q3 | $13K | Buy |
834
+357
| +75% | +$5.57K | ﹤0.01% | 6347 |
|
|
2021
Q2 | $11K | Buy |
+477
| New | +$11K | ﹤0.01% | 6336 |
|